Literature DB >> 20823285

Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics.

Barbara Claus, Franky Buyle, Hugo Robays, Dirk Vogelaers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20823285      PMCID: PMC2976155          DOI: 10.1128/AAC.00754-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.

Authors:  Thomas P Lodise; Ben Lomaestro; George L Drusano
Journal:  Clin Infect Dis       Date:  2007-01-02       Impact factor: 9.079

2.  Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.

Authors:  Gita Wasan Patel; Nimish Patel; Asma Lat; Kristen Trombley; Sam Enbawe; Kelli Manor; Raymond Smith; Thomas P Lodise
Journal:  Diagn Microbiol Infect Dis       Date:  2009-06       Impact factor: 2.803

Review 3.  A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics.

Authors:  Jason A Roberts; Steven Webb; David Paterson; Kwok M Ho; Jeffrey Lipman
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

4.  Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients.

Authors:  N Patel; M H Scheetz; G L Drusano; T P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

5.  Flushing an i.v. line: a simple but potentially costly procedure for both patient and health unit.

Authors:  Karen Wotton; Lee-Anne Gassner; Eileen Ingham
Journal:  Contemp Nurse       Date:  2004-10       Impact factor: 1.787

  5 in total
  1 in total

1.  A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals.

Authors:  F M Buyle; J Decruyenaere; J De Waele; P M Tulkens; T Van Audenrode; P Depuydt; G Claeys; H Robays; D Vogelaers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-28       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.